A composite MyD88/CD40 switch synergistically activates mouse and human dendritic cells for enhanced antitumor efficacyPriyadharshini Narayanan(Baylor College of Medicine), David M. Spencer(Saint Louis University)Journal of Clinical InvestigationMarch 7, 201110.1172/jci44327Cited by 54SaveCiteExport RISWatch citationsRelated PapersNotch and TGFβ Form a Reciprocal Positive Regulatory Loop that Suppresses Murine Prostate Basal Stem/Progenitor Cell Activity|Cell stem cell|2012|94MyD88/CD40 Genetic Adjuvant Function in Cutaneous Atypical Antigen-Presenting Cells Contributes to DNA Vaccine Immunogenicity|PLoS ONE|2016|5